Back
Akero Therapeutics 10K Form
Sell
38
AKRO
Akero Therapeutics
Last Price:
29.62
Seasonality Move:
-5.94%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AKRO News And Ratings
See the #1 stock for the next 7 days that we like better than AKRO
AKRO Financial Statistics
Sales & Book Value
Annual Sales: | -- |
---|---|
Cash Flow: | $-58.45M |
Price / Cash Flow: | 0 |
Annual Sales: | $11.53 |
Price / Book: | 2.58 |
Profitability
EPS (TTM): | -3.44000 |
---|---|
Net Income (TTM): | $-204.18M |
Gross Margin: | -- |
Return on Equity: | 0% |
Return on Assets: | 0% |
Akero Therapeutics Earnings Forecast
Key Akero Therapeutics Financial Ratios
- The Interest Expense is -2.04% of Operating Income.
- Per Share Earnings over the last 6 years have been positive in 3 years.
Akero Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | AKRO |
CUSIP: | 00973Y |
Website: | akerotx.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
AKRO Technical Analysis vs Fundamental Analysis
Sell
38
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy or a Sell?
-
Akero Therapeutics stock is rated a Sell
The current Akero Therapeutics [AKRO] share price is $29.63. The Score for AKRO is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.